Drugs / ALK-Flex SQ
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00857779 Comparator | Feb → Aug 2009 | asthma, conjunctivitis, rhinitis | ALK-Abelló A/S | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ALK-Flex SQ | “A Multicentre Randomised Phase II Clinical Trial to Demonstrate Equivalent Pharmacodynamic Efficacy and Tolerability of Two Updosing Schedules for ALK-Flex SQ” NCT00857779 ↗ |
| Route | Subcutaneous | “subcutaneous immunotherapy” NCT00857779 ↗ |